Jinyu Bio-technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	1,297	1,225	1,508	1,485	1,754	1,567
Other Revenue	30.13	30.13	89.92	43.97	22.64	14.59
Revenue	1,327	1,255	1,598	1,529	1,776	1,582
Revenue Growth (YoY)	-1.70%	-21.45%	4.55%	-13.94%	12.29%	40.39%
Cost of Revenue	652.67	597.17	668.1	697.3	688.81	621.66
Gross Profit	674.39	658.29	930.13	831.37	1,088	960.25
Selling, General & Admin	500.35	432.34	491.55	421.77	501.9	400.14
Research & Development	144.81	136.82	143.47	133.78	165.94	130.83
Other Operating Expenses	42.83	21.83	23.14	22.26	24.5	23.24
Operating Expenses	731.32	621.1	681.43	579.36	693.32	553.26
Operating Income	-56.93	37.19	248.7	252.01	394.19	406.99
Interest Expense	-0.75	-5.5	-0.05	-4.81	-0.04	-0.97
Interest & Investment Income	67.75	55.36	56.52	50.91	47.57	45.06
Currency Exchange Gain (Loss)	0.05	0.05	-0.02	0.08	-0.05	-0.21
Other Non Operating Income (Expenses)	-0.81	-0.58	0.15	0.21	-0.76	-1.89
EBT Excluding Unusual Items	9.3	86.52	305.28	298.39	440.91	448.97
Impairment of Goodwill	-3.21	-3.21	-18.08	-65.02	-39.75	-
Gain (Loss) on Sale of Investments	-1.31	-9.49	-7.78	-9.81	-3.22	8.48
Gain (Loss) on Sale of Assets	10.84	2.58	-0.04	-0.04	-2.31	0.04
Asset Writedown	0.95	-11.11	-5.34	-1.54	-1.99	-0.4
Other Unusual Items	93.92	59.63	41.78	23.61	19.65	19.12
Pretax Income	110.49	124.91	315.83	245.58	413.27	476.21
Income Tax Expense	17.39	20.76	38.73	45.46	24.27	53.82
Earnings From Continuing Operations	93.1	104.15	277.1	200.12	389.01	422.39
Minority Interest in Earnings	7.66	4.83	6.53	10.54	-6.72	-16.19
Net Income	100.76	108.99	283.63	210.66	382.29	406.2
Net Income to Common	100.76	108.99	283.63	210.66	382.29	406.2
Net Income Growth	-38.88%	-61.58%	34.64%	-44.90%	-5.89%	83.76%
Shares Outstanding (Basic)	1,049	1,090	1,091	1,109	1,124	1,128
Shares Outstanding (Diluted)	1,049	1,090	1,091	1,109	1,124	1,128
Shares Change (YoY)	-5.26%	-0.10%	-1.61%	-1.39%	-0.35%	2.09%
EPS (Basic)	0.10	0.10	0.26	0.19	0.34	0.36
EPS (Diluted)	0.10	0.10	0.26	0.19	0.34	0.36
EPS Growth	-35.49%	-61.54%	36.84%	-44.12%	-5.56%	80.00%
Free Cash Flow	186.87	199.89	141.67	154.54	160.4	471.3
Free Cash Flow Per Share	0.18	0.18	0.13	0.14	0.14	0.42
Dividend Per Share	0.030	0.030	0.080	0.060	0.110	0.120
Dividend Growth	-62.50%	-62.50%	33.33%	-45.45%	-8.33%	100.00%
Gross Margin	50.82%	52.43%	58.20%	54.38%	61.22%	60.70%
Operating Margin	-4.29%	2.96%	15.56%	16.49%	22.19%	25.73%
Profit Margin	7.59%	8.68%	17.75%	13.78%	21.52%	25.68%
Free Cash Flow Margin	14.08%	15.92%	8.86%	10.11%	9.03%	29.79%
EBITDA	168.2	246.61	437.17	450.92	585.17	580.63
EBITDA Margin	12.68%	19.64%	27.35%	29.50%	32.94%	36.70%
D&A For EBITDA	225.12	209.42	188.47	198.91	190.98	173.64
EBIT	-56.93	37.19	248.7	252.01	394.19	406.99
EBIT Margin	-4.29%	2.96%	15.56%	16.48%	22.19%	25.73%
Effective Tax Rate	15.74%	16.62%	12.26%	18.51%	5.87%	11.30%
Revenue as Reported	1,327	1,255	1,598	1,529	1,776	1,582
Advertising Expenses	-	162.42	179.06	166.38	241.94	172.68

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.